Journal Watch · Diabetes Care · 2026
13. Older Adults: Standards of Care in Diabetes-2026.
Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
TL;DR
Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
Key findings
- For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations and a full list of Professional Practice Committee members, please refer to Introduction and Methodology.
- Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
What they did
Members of the ADA Professional Practice Committee for Diabetes, an interprofessional expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted.
Full abstract (original)
Background: The American Diabetes Association (ADA) "Standards of Care in Diabetes" includes the ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care.
What they did: Members of the ADA Professional Practice Committee for Diabetes, an interprofessional expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted.
Results & conclusions: For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations and a full list of Professional Practice Committee members, please refer to Introduction and Methodology. Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
Abstract © the authors / Diabetes Care (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.2337/dc26-s013 · PubMed 41358888.
Why it matters for pharma & biotech
- Relevant to Pharmacology & Drug Discovery teams tracking Diabetes Care for new targets, mechanisms and biomarkers.
- As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
- For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.
Limitations & what to check in the full text
- This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
- The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.
Frequently asked questions
What did this Diabetes Care study find?
Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
What type of study is this?
It is a research study, published in Diabetes Care in 2026. Members of the ADA Professional Practice Committee for Diabetes, an interprofessional expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted.
Where can I read the original paper?
The original is at the publisher via DOI 10.2337/dc26-s013. PubMed ID: 41358888. BioStudioAI reproduces the abstract for discussion and links to the source.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/13-older-adults-standards-of-care-in-diabetes-2026-26s013/
Reading papers is step one. Analysing the data is the work.
BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.
Open BioStudioAI More guides